Your search returned 1550 results.

Results
	1.	New Life to an Old Treatment: Pegylated Interferon Beta 1a in the Management of Multiple Sclerosis. [electronic resource] by Ortiz, Miguel Angel Espino-Paisan, Laura Nunez, Concepcion Alvarez-Lafuente, Roberto Urcelay, Elena Producer: 20180913 In: Current medicinal chemistry vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Interferon beta treatment for multiple sclerosis. [electronic resource] by Johnson, K P Panitch, H S Producer: 19990225 In: Lancet (London, England) vol. 353 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Is the 'MS establishment' biased; the case for addressing gender inequality in the field of MS? [electronic resource] by Giovannoni, Gavin Producer: 20200220 In: Multiple sclerosis and related disorders vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The potential teratogenic effects of interferon beta-1a and interferon beta-1b on in vitro embryonic development. [electronic resource] by Uçar, I Ertekin, T Nisari, M Ceylan, D Al, Ö Ülger, H Producer: 20181011 In: Folia morphologica vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Maintaining consistent quality and clinical performance of biopharmaceuticals. [electronic resource] by Lamanna, William C Holzmann, Johann Cohen, Hillel P Guo, Xinghua Schweigler, Monika Stangler, Thomas Seidl, Andreas Schiestl, Martin Producer: 20181211 In: Expert opinion on biological therapy vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	[High risk patient profit from early treatment with interferon beta 1a]. [electronic resource] Producer: 20030319 In: Fortschritte der Neurologie-Psychiatrie vol. 71 Availability: No items available. Save to lists Add to cart (remove)
	7.	Commentary on "Localized pigmentation disorder after subcutaneous pegylated interferon beta 1a injection" by Coghe et al. [electronic resource] by Porter, Bernadette Producer: 20190327 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	[Advances in the therapy of multiple sclerosis with interferon beta-1a]. [electronic resource] Producer: 19971230 In: Der Nervenarzt vol. 68 Availability: No items available. Save to lists Add to cart (remove)
	9.	Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies? [electronic resource] by Heidenreich, F Producer: 20160125 In: Journal of neurology, neurosurgery, and psychiatry vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Subacute cutaneous lupus erythematosus associated with interferon beta-1a. [electronic resource] by Nousari, H C Kimyai-Asadi, A Tausk, F A Producer: 19981230 In: Lancet (London, England) vol. 352 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Interferon beta for Guillain-Barré syndrome. [electronic resource] by Sawaya, R A Producer: 19981204 In: Lancet (London, England) vol. 352 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	[Report on the Satellite Symposium "Thinking forward--critical problems of therapy. 17th Congress ECTRIMS. Dublin (Ireland), 14.09.2001]. [electronic resource] by Cendrowski, Wojciech Producer: 20020710 In: Neurologia i neurochirurgia polska vol. 36 Availability: No items available. Save to lists Add to cart (remove)
	13.	Disease modifying therapies in multiple sclerosis. [electronic resource] by Fox, Robert J Fisher, Elizabeth Rudick, Richard Producer: 20020903 In: Neurology vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies. [electronic resource] by Comi, Giancarlo Alroughani, Raed Boster, Aaron L Bass, Ann D Berkovich, Regina Fernández, Óscar Kim, Ho Jin Limmroth, Volker Lycke, Jan Macdonell, Richard Al Sharrack, Basil Singer, Barry A Vermersch, Patrick Wiendl, Heinz Ziemssen, Tjalf Jacobs, Alan Daizadeh, Nadia Rodriguez, Claudio E Traboulsee, Anthony Producer: 20210924 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta 1a (IFN beta-1a) products administered intramuscularly in healthy male and female volunteers. [electronic resource] by Borden, E C Producer: 19980327 In: Pharmaceutical research vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta 1a (IFN beta-1a) products administered intramuscularly in healthy male and female volunteers. [electronic resource] by Fumero, S Producer: 19980327 In: Pharmaceutical research vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosis. [electronic resource] by Mowry, Ellen M Corboy, John R Producer: 20200602 In: The Lancet. Neurology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	[Comparison of pharmacokinetic and pharmacodynamic data of interferon-beta 1a preparations after intramuscular and subcutaneous administration]. [electronic resource] by Gruber, R Producer: 19981217 In: Arzneimittel-Forschung vol. 48 Availability: No items available. Save to lists Add to cart (remove)
	19.	Marked hypertriglyceridemia induced by interferon-β1a therapy in a clinically isolated syndrome patient. [electronic resource] by Kawahara, Yuko Yamashita, Toru Ohta, Yasuyuki Sato, Kota Tsunoda, Keiichiro Takemoto, Mami Hishikawa, Nozomi Eguchi, Jun Abe, Koji Producer: 20170531 In: Journal of the neurological sciences vol. 373 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Practice advisory on selection of patients with multiple sclerosis for treatment with Betaseron. Report of the Quality Standards Subcommittee of the American Academy of Neurology. [electronic resource] Producer: 19940912 In: Neurology vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1550 results.